News | News By Subject | News by Disease News By Date | Search News

Breast Cancer News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Merrimack (MACK) Halts Phase II HERMIONE Study for Breast Cancer; Further Plans Revealed in January     12/22/2016
Celgene (CELG) Decides to Not Move Forward With Phase III Portion of tnAcity     12/7/2016
NICE U-Turns and Backs Approval of Roche (RHHBY)'s Perjeta for HER2-Positive Breast Cancer     11/22/2016
Puma Biotech (PBYI) Crashes After Diarrhea Risk is Linked to Breast Cancer Drug in Abstract     11/16/2016
Eli Lilly (LLY)'s Breast Cancer Drug Failed to Meet Phase III Goals, But Panel Recommends Continuation of Trial     8/10/2016
FDA Bestows Novartis AG (NVS)'s Breast Cancer Pill With Breakthrough Tag     8/3/2016
Amgen (AMGN) And Allergan (AGN) Biosimilar Found as Effective as Genentech (RHHBY)'s Herceptin     7/21/2016
Galena Biopharma  (GALE) Craters and Discontinues Phase III Breast Cancer Vaccine NeuVax     6/30/2016
ASCO2016: Mylan (MYL)-BioCon (BIOCON.NS)'s Biosimilar Cancer Drug Comparable to Roche (RHHBY)'s Herceptin     6/6/2016
ASCO2016: Immunomedics (IMMU) Breast Cancer Abstract Booted from Conference     6/6/2016
Nektar Therapeutics (NKTR), DAIICHI SANKYO EUROPE GmbH Strike $80 Million+ ONZEALD Pact     6/1/2016
Novartis AG (NVS) Trial Stopped Early on Positive Data, Gets Ready to Take on Pfizer (PFE)'s Ibrance     5/31/2016
AstraZeneca PLC (AZN)'s Fulvestrant Meets Goals in Phase III Study     5/27/2016
SoCal's Puma Biotech (PBYI) Delays NDA for Neratinib to Treat Breast Cancer Until Mid-2016     3/29/2016
10 Massachusetts Biotechs that Grew Their Headcount by at Least 40% in 2015     3/24/2016

News from Around the Web
Were Women Foolish To Follow Angelina Jolie Into BRCA Cancer Gene Testing?     1/5/2017
Breast Cancer Cells Do Not Like It Spicy, Ruhr-University Study     12/22/2016
How 3 Huge Discoveries in 2016 are Moving Us Closer to a Breast Cancer Cure     10/24/2016
Puma Biotech (PBYI)'s $150 Million Stock Offering May Signal to Investors That Its Breast Cancer Drug is in Trouble     10/20/2016
Mammograms More Likely To Cause Unneeded Treatment Than To Save Lives, Published In BMJ     10/13/2016
Newly Developed: Non-Invasive, Safe Tester For Breast Cancer Diagnosis, Polish Biotech Braster Reveals     10/7/2016
Implant Improves Breast Cancer Survival, University of Michigan Study     9/30/2016
Want A BRCA Test? Some Insurers Require Genetic Counseling First     9/19/2016
Simple Blood Test Could Be Used To Detect Breast Cancer, University of Western Australia Study     9/9/2016
New Platform Hopes To Speed Diagnosis Of Parkinson's Disease And Breast Cancer, Oxford Impedance Diagnostics Reveals     8/1/2016
New Review Concludes Evidence For Alcohol Causing Cancer Is Strong, University Of Otago Study     7/22/2016
Got Dense Breasts? That Can Depend On Who Is Reading The Mammogram, University of Vermont Study     7/19/2016
Hops Extract Could Help Reduce Breast Cancer Risk, University of Illinois Study     7/12/2016
Why Do More Black Women Die of Breast Cancer? NIH Study     7/8/2016
NASA Technology Reveals Bacteria's Role In Breast Cancer     6/28/2016

Press Releases
Daiichi Sankyo Release: Company Initiates Phase 1/2 Study Of Novel Antibody Drug Conjugate U3-1402 In Patients With HER3-Positive Metastatic Or Unresectable Breast Cancer     1/18/2017
Mylan (MYL) Release: FDA Accepts Biologics License Application (BLA) For Pharma And BioCon (BIOCON.NS)'s Proposed Biosimilar Trastuzumab     1/11/2017
OncoTAb Release: Company Presentation To Highlight Results Of Study On A Blood-Test Based Multi-Modal Screening Strategy For Early Breast Cancer Detection At Biotech Showcase Conference     1/11/2017
G1 Therapeutics Release: Biotech Initiates Three Drug Development Programs In Breast Cancer     1/10/2017
Experimental Biology and Medicine Release: Gleevec: A Possible Therapeutic Drug For Notch And/Or C-Myc Positive Breast Cancer     1/10/2017
Cynvenio Releases Second-Generation ClearID Breast Cancer Blood Test     1/9/2017
Cascadian Therapeutics (ONTY) Announces 2017 Outlook And Recent Drug Portfolio Progress     1/5/2017
Columbia-Presbyterian Medical Center Sponsors Clinical Study Using Biocept's Liquid Biopsy Platform To Evaluate Cerebrospinal Fluid Of Breast Cancer Patients For Metastatic Biomarkers     12/27/2016
Prima Biomed (PRR.AX) Announces Data From IMP321 AIPAC Clinical Trial In Breast Cancer     12/22/2016
FDA Accepts Supplemental New Drug Application For Pfizer (PFE)’s IBRANCE (Palbociclib) In HR+, HER2- Metastatic Breast Cancer     12/21/2016
Fraunhofer: Scientists Discover New Mechanisms Of Early Metastatic Spread In Breast Cancer     12/15/2016
Agendia BV Release: Three New Studies Presented At San Antonio Breast Cancer Symposium Further Demonstrate Value Of Mammaprint And Blueprint In Individualizing Treatment For Breast Cancer Patients     12/14/2016
Innocrin Presents Data From The Ongoing Phase II Trial Of Seviteronel In Estrogen Receptor-Positive Or Triple-Negative Breast Cancer (CLARITY-01) At The San Antonio Breast Cancer Symposium     12/13/2016
Lightpoint Medical Announces Clinical Trial Results Of Intraoperative Imaging Technology In Breast Cancer Surgery     12/13/2016
Corcept Therapeutics Inc. (CORT) Announces Encouraging Results Of Phase 1/2 Trial Of Mifepristone Plus Eribulin In Triple-Negative Breast Cancer     12/12/2016